Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : wla(warner lambert) -- Ignore unavailable to you. Want to Upgrade?

To: Anton P. Porsteinsson who wrote (901)	11/10/1999 5:01:00 AM
From: Charles Broderick	Respond to of 942

Can anyone here tell me if it would be unusual for a company like Merrill Lynch to take a stake (say 6%) in a pharmaceutical research company???

To: Anton P. Porsteinsson who wrote (901)	11/10/1999 5:57:00 AM
From: James Baker	Read Replies (1) \| Respond to of 942

You are confusing past history and future pipeline. PFE has stalled badly recently with Trovan problems, big delay in migraine drug and nothing on the horizon to be marketed soon. Spending on R&D is great but "where's the beef"? Some of PFE best sellers are not even theirs; Celebrex [Searle] Lipator [WLA]. Where are the PFE originals??? AHP has new drugs and vaccine just getting approval. New drugs and markets for AHP in next two years much brighter than for PFE.